Empagliflozin induced euglycemic diabetic ketoacidosis in a patient undergoing coronary artery bypass graft despite discontinuation of the drug 48 hours prior to the surgery

Publication date: Available online 22 April 2021Source: Diabetes & Metabolic Syndrome: Clinical Research & ReviewsAuthor(s): Mohammad Shafi Kuchay, Sunil Kumar Mishra, Yatin Mehta
Source: Diabetes and Metabolic Syndrome: Clinical Research and Reviews - Category: Endocrinology Source Type: research